Cancer is a disease of uncontrolled cell growth. Cancer cells grow abnormally because of damage to their DNA. This DNA damage garbles the genetic signals for normal growth. The molecular approach to cancer gets to the heart of the matter. Molecular studies have uncovered many of the details whereby a normal cell becomes cancerous. These discoveries have revealed cancer to be a multistep process, involving the progressive loss of control by the malignant cell, failure of DNA repair, and of loss of backup systems for preventing abnormal cell growth. We have discovered oncogenes, which promote tumor growth, as well as anti-oncogenes, which suppress tumors.


Chronic Myeloid Leukemia Human Papilloma Virus Follicular Lymphoma Acute Promyelocytic Leukemia Gene Rearrangement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ayscue LH, Ross DW, Ozer H, Rao K, Gulley ML, Dent GA (1990) Bcr/abl recombinant DNA analysis versus karyotype in the diagnosis and therapeutic monitoring of chronic myeloid leukemia. Am J Clin Pathol 94: 404–409.PubMedGoogle Scholar
  2. Bayever E, Iversen P (1994) Oligonucleotides in the treatment of leukemia. Hematol Oncol 12: 9–14.PubMedCrossRefGoogle Scholar
  3. Burkitt D, O’Conor GT (1961) Malignant lymphoma in African children I. A clinical syndrome. Cancer 14: 258–269.PubMedCrossRefGoogle Scholar
  4. Cole HM (ed) (1993) Diagnostic and therapeutic technology assessment: human papillomavirus DNA testing in the management of cervical neoplasia. JAMA 270: 2975–2981.CrossRefGoogle Scholar
  5. Cossman J (ed) (1990) Molecular Genetics in Cancer Diagnosis. Elsevier, NY.Google Scholar
  6. Cossman J, Zehnbauer B, Garrett CT, Smith LJ, Williams M, Jaffe ES, Hanson LO, Love J (1991) Gene rearrangements in the diagnosis of lymphoma/leukemia. Am J Clin Pathol 95: 347–354.PubMedGoogle Scholar
  7. Daley GQ, van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 247: 824–830.PubMedCrossRefGoogle Scholar
  8. de The H, Chomienne C, Lanotte M, Degos L, Dejean A (1990) The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558–561.PubMedCrossRefGoogle Scholar
  9. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 6 (61): 759–767.CrossRefGoogle Scholar
  10. Gulley ML, Dent GA, Ross DW (1992) Classification and staging of lymphoma by molecular genetics. Cancer (Suppl) 69: 1600–1606.CrossRefGoogle Scholar
  11. Hamilton SR (1992) Molecular genetics of colorectal carcinoma. Cancer 70: 1216–1221.PubMedCrossRefGoogle Scholar
  12. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329: 1318–1327.PubMedCrossRefGoogle Scholar
  13. Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G (1985) Structural organization of the bcr gene and its role in the Ph’ translocation. Nature 315: 758–761.PubMedCrossRefGoogle Scholar
  14. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bc1–2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336.PubMedCrossRefGoogle Scholar
  15. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49–53.Google Scholar
  16. Huang ME, Ye YI, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567–571.PubMedGoogle Scholar
  17. Jacquemier J, Penault F, Durst M, Parc P, Seradour B, Meynard P, Halfon P, Hassoun J (1990) Detection of five different human papillomavirus types in cervical lesions by in situ hybridization. Hum Pathol 21: 911–917.PubMedCrossRefGoogle Scholar
  18. Jen J, Kim H, Piantadosi S, et al. (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213–221.PubMedCrossRefGoogle Scholar
  19. Kern SE, Fearon ER, Tersmette KWF, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B, Hamilton S (1989) Allelic loss in colorectal carcinoma. JAMA 261 (21): 3099–3103.PubMedCrossRefGoogle Scholar
  20. Lane DP (1994) p53 and human cancers. Br Med Bull 50:582–599.PubMedGoogle Scholar
  21. Longo L, Pandolfi PP, Biondi A, Rambaldi A, Mencarelli A, Lo Coco F, Diverio D, Pegoraro L, Avanzi G, Tabilio A, Zangrilli D, Alcalay M, Donti E, Grignani F, Pelicci PG (1990) Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. J Exp Med 172: 1571–1575.PubMedCrossRefGoogle Scholar
  22. Lyons J, private communication; see also Lyons J, Landis CA, Harsh G, et al. (1990) Two G protein oncogenes in human endocrine tumors. Science 249: 655–659.PubMedCrossRefGoogle Scholar
  23. McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254–256.PubMedCrossRefGoogle Scholar
  24. National Advisory Council for Human Genome Research (1994) Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 271: 785.CrossRefGoogle Scholar
  25. Ross DW, Brunning RD, Kantarjian HM, Koeffler HP, Ozer H (1993) A proposed staging system for chronic myeloid leukemia, Cancer 71: 3788–3791.PubMedCrossRefGoogle Scholar
  26. Shattuck-Eidens D, McClure H, Simard J, et al. (1995) A collaborative survey of 80 mutations in the brcal breast and ovarian cancer susceptibility gene. JAMA 273: 535–541.PubMedCrossRefGoogle Scholar
  27. Slamon DJ, Godolphin W, Jones LA, et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712.PubMedCrossRefGoogle Scholar
  28. Stanbridge EF, Nowell PC (1990) Origins of human cancer revisited. Cell 63: 867–874.PubMedCrossRefGoogle Scholar
  29. zur Hausen H (1987) Papillomaviruses in human cancer. Cancer 59: 1692–1696.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  1. 1.The School of Medicine, Department of PathologyUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.Department of PathologyForsyth Memorial HospitalWinston-SalemUSA

Personalised recommendations